Provided by Tiger Fintech (Singapore) Pte. Ltd.

89Bio, Inc.

7.78
+0.13501.77%
Post-market: 7.850.0750+0.96%18:55 EDT
Volume:1.05M
Turnover:8.15M
Market Cap:1.14B
PE:-2.36
High:7.87
Open:7.79
Low:7.46
Close:7.64
Loading ...

Citi says SMid biotechs alternative to large caps as it starts coverage

Investing.com
·
13 Mar

89Bio Shares up 2% After Citigroup Initiates Coverage With 'Buy' Rating

THOMSON REUTERS
·
13 Mar

89Bio Shares up 3.6% Premarket After Citigroup Initiates Coverage With 'Buy' Rating

THOMSON REUTERS
·
13 Mar

BUZZ-Citi initiates coverage on 89bio with 'buy' rating on potential for MASH therapy

Reuters
·
13 Mar

Citigroup Initiates 89bio Inc at Buy With $25 Price Target

MT Newswires Live
·
13 Mar

BUZZ-Citi starts coverage on 'insulated' SMid biotechs amid healthcare policy uncertainty

Reuters
·
13 Mar

Is 89BIO (ETNB) Stock Outpacing Its Medical Peers This Year?

Zacks
·
06 Mar

Evercore ISI Sticks to Its Buy Rating for 89bio (ETNB)

TIPRANKS
·
06 Mar

Analysts Conflicted on These Healthcare Names: Cytokinetics (CYTK), Warby Parker (WRBY) and 89bio (ETNB)

TIPRANKS
·
03 Mar

Bank of America Securities Keeps Their Buy Rating on 89bio (ETNB)

TIPRANKS
·
02 Mar

89Bio Inc. Faces Financial Risks Amid Market Challenges for Approved Products

TIPRANKS
·
01 Mar

Analysts Are Bullish on Top Healthcare Stocks: 89bio (ETNB), Lemaitre Vascular (LMAT)

TIPRANKS
·
01 Mar

89bio Price Target Cut to $21.00/Share From $29.00 by HC Wainwright & Co.

Dow Jones
·
01 Mar

89bio price target lowered to $21 from $29 at H.C. Wainwright

TIPRANKS
·
01 Mar

89Bio, Inc. : H.c. Wainwright Cuts Target Price to $21 From $29

THOMSON REUTERS
·
01 Mar

89Bio Inc : Raymond James Raises Target Price to $51 From $49

THOMSON REUTERS
·
28 Feb

89Bio Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

89bio reports Q4 EPS ($1.02), consensus (76c)

TIPRANKS
·
28 Feb

89bio Q4 2024 GAAP EPS $(1.02) Misses $(0.77) Estimate

Benzinga
·
28 Feb

89bio Q4 Net Income USD -118.354 Million Vs. IBES Estimate USD -84.1 Million

Reuters
·
28 Feb